CNI-1493	O
inhibits	O
monocyte/macrophage	B-protein
tumor	I-protein
necrosis	I-protein
factor	I-protein
by	O
suppression	O
of	O
translation	O
efficiency	O
.	O

Tumor	B-protein
necrosis	I-protein
factor	I-protein
(	O
TNF	B-protein
)	O
mediates	O
a	O
wide	O
variety	O
of	O
disease	O
states	O
including	O
septic	O
shock	O
,	O
acute	O
and	O
chronic	O
inflammation	O
,	O
and	O
cachexia	O
.	O

Recently	O
,	O
a	O
multivalent	O
guanylhydrazone	O
(	O
CNI-1493	O
)	O
developed	O
as	O
an	O
inhibitor	O
of	O
macrophage	O
activation	O
was	O
shown	O
to	O
suppress	O
TNF	B-protein
production	O
and	O
protect	O
against	O
tissue	O
inflammation	O
and	O
endotoxin	O
lethality	O
[	O
Bianchi	O
,	O
M.	O
,	O
Ulrich	O
,	O
P.	O
,	O
Bloom	O
,	O
O.	O
,	O
Meistrell	O
,	O
M.	O
,	O
Zimmerman	O
,	O
G.A.	O
,	O
Schmidtmayerova	O
,	O
H.	O
,	O
Bukrinsky	O
,	O
M.	O
,	O
Donnelley	O
,	O
T.	O
,	O
Bucala	O
,	O
R.	O
,	O
Sherry	O
,	O
B.	O
,	O
Manogue	O
,	O
K.R.	O
,	O
Tortolani	O
,	O
A.J.	O
,	O
Cerami	O
,	O
A.	O
&	O
Tracey	O
,	O
K.J.	O
(	O
1995	O
)	O
Mol.Med.1	O
,	O
254-266	O
,	O
and	O
Bianchi	O
,	O
M.	O
,	O
Bloom	O
,	O
O.	O
,	O
Raabe	O
,	O
T.	O
,	O
Cohen	O
,	O
P.	O
S.	O
,	O
Chesney	O
,	O
J.	O
,	O
Sherry	O
,	O
B.	O
,	O
Schmidtmayerova	O
,	O
H.	O
,	O
Zhang	O
,	O
X.	O
,	O
Bukrinsky	O
,	O
M.	O
,	O
Ulrich	O
,	O
P.	O
,	O
Cerami	O
,	O
A.	O
&	O
Tracey	O
,	O
J.	O
(	O
1996	O
)	O
J.Exp.Med.	O
,	O
in	O
press	O
]	O
.	O

We	O
have	O
now	O
elucidated	O
the	O
mechanism	O
by	O
which	O
CNI-1493	O
inhibits	O
macrophage	O
TNF	B-protein
synthesis	O
and	O
show	O
here	O
that	O
it	O
acts	O
through	O
suppression	O
of	O
TNF	B-protein
translation	O
efficiency	O
.	O

CNI-1493	O
blocked	O
neither	O
the	O
lipopolysaccharide	O
(	O
LPS	O
)	O
-induced	O
increases	O
in	O
the	O
expression	O
of	O
TNF	B-RNA
mRNA	I-RNA
nor	O
the	O
translocation	O
of	O
nuclear	B-protein
factor	I-protein
NF-kappa	I-protein
B	I-protein
to	O
the	O
nucleus	O
in	O
macrophages	B-cell_type
activated	O
by	O
15	O
min	O
of	O
LPS	O
stimulation	O
,	O
indicating	O
that	O
CNI-1493	O
does	O
not	O
interfere	O
with	O
early	O
NF-kappa	B-protein
B	I-protein
-mediated	O
transcriptional	O
regulation	O
of	O
TNF	B-protein
.	O

However	O
,	O
synthesis	O
of	O
the	O
26-kDa	B-protein
membrane	I-protein
form	I-protein
of	O
TNF	B-protein
was	O
effectively	O
blocked	O
by	O
CNI-1493	O
.	O

Further	O
evidence	O
for	O
the	O
translational	O
suppression	O
of	O
TNF	B-protein
is	O
given	O
by	O
experiments	O
using	O
chloram-phenicol	B-DNA
acetyltransferase	I-DNA
(	I-DNA
CAT	I-DNA
)	I-DNA
constructs	I-DNA
containing	O
elements	O
of	O
the	O
TNF	B-DNA
gene	I-DNA
that	O
are	O
involved	O
in	O
TNF	B-protein
translational	O
regulation	O
.	O

Both	O
the	O
5	B-DNA
'	I-DNA
and	I-DNA
3	I-DNA
'	I-DNA
untranslated	I-DNA
regions	I-DNA
of	O
the	O
TNF	B-DNA
gene	I-DNA
were	O
required	O
to	O
elicit	O
maximal	O
translational	O
suppression	O
by	O
CNI-1493	O
.	O

Identification	O
of	O
the	O
molecular	O
target	O
through	O
which	O
CNI-	O
1493	O
inhibits	O
TNF	B-protein
translation	O
should	O
provide	O
insight	O
into	O
the	O
regulation	O
of	O
macrophage	O
activation	O
and	O
mechanisms	O
of	O
inflammation	O
.	O

bProc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sei	NULL
.	NULL

USA	NULL
Vol	NULL
.	NULL

93	NULL
,	NULL
pp	NULL
.	NULL

3967-3971	NULL
,	NULL
April	NULL
1996	NULL
Medical	NULL
Sciences	NULL
CNI-1493	NULL
inhibits	NULL
monocyte	NULL
/macrophage	NULL
tumor	NULL
necrosis	NULL
factor	NULL
by	NULL
suppression	NULL
of	NULL
translation	NULL
efficiency	NULL
PamELA	NULL
S.	NULL
ConEn*t	NULL
,	NULL
HARIKRISHNA	NULL
NAKSHATRI*	NULL
,	NULL
JamEEL	NULL
DenNnIs*	NULL
,	NULL
THERESA	NULL
CARAGINE*	NULL
,	NULL
MARINA	NULL
BrancHt*	NULL
,	NULL
ANTHONY	NULL
CERAMI*	NULL
,	NULL
AND	NULL
Kevin	NULL
J.	NULL
Tracey*t	NULL
*Laboratory	NULL
of	NULL
Biomedical	NULL
Sciences	NULL
,	NULL
Picower	NULL
Institute	NULL
for	NULL
Medical	NULL
Research	NULL
,	NULL
Manhasset	NULL
,	NULL
NY	NULL
11030	NULL
;	NULL
and	NULL
*Department	NULL
of	NULL
Pediatrics	NULL
,	NULL
Division	NULL
of	NULL
Pediatric	NULL
Hematology-Oncology	NULL
,	NULL
and	NULL
*Department	NULL
of	NULL
Surgery	NULL
,	NULL
North	NULL
Shore	NULL
University	NULL
Hospital	NULL
,	NULL
Manhasset	NULL
,	NULL
NY	NULL
11030	NULL
Contributed	NULL
by	NULL
Anthony	NULL
Cerami	NULL
,	NULL
December	NULL
26	NULL
,	NULL
1995	NULL
ABSTRACT	NULL
Tumor	NULL
necrosis	NULL
factor	NULL
(	NULL
TNF	NULL
)	NULL
mediates	NULL
a	NULL
wide	NULL
variety	NULL
of	NULL
disease	NULL
states	NULL
including	NULL
septic	NULL
shock	NULL
,	NULL
acute	NULL
and	NULL
chronic	NULL
inflammation	NULL
,	NULL
and	NULL
cachexia	NULL
.	NULL

Recently	NULL
,	NULL
a	NULL
multivalent	NULL
guanylhydrazone	NULL
(	NULL
CNI-1493	NULL
)	NULL
developed	NULL
as	NULL
an	NULL
inhibitor	NULL
of	NULL
macrophage	NULL
activation	NULL
was	NULL
shown	NULL
to	NULL
suppress	NULL
TNF	NULL
production	NULL
and	NULL
protect	NULL
against	NULL
tissue	NULL
inflammation	NULL
and	NULL
endotoxin	NULL
lethality	NULL
[	NULL
Bianchi	NULL
,	NULL
M.	NULL
,	NULL
Ulrich	NULL
,	NULL
P.	NULL
,	NULL
Bloom	NULL
,	NULL
O.	NULL
,	NULL
Meistrell	NULL
,	NULL
M.	NULL
,	NULL
Zimmerman	NULL
,	NULL
G.	NULL
A.	NULL
,	NULL
Schmidtmayerova	NULL
,	NULL
H.	NULL
,	NULL
Bukrinsky	NULL
,	NULL
M.	NULL
,	NULL
Donnelley	NULL
,	NULL
T.	NULL
,	NULL
Bucala	NULL
,	NULL
R.	NULL
,	NULL
Sherry	NULL
,	NULL
B.	NULL
,	NULL
Manogue	NULL
,	NULL
K.	NULL
R.	NULL
,	NULL
Tortolani	NULL
,	NULL
A.	NULL
J.	NULL
,	NULL
Cerami	NULL
,	NULL
A	NULL
.	NULL

&	NULL
Tracey	NULL
,	NULL
K.	NULL
J	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Mol	NULL
.	NULL

Med	NULL
.	NULL

1	NULL
,	NULL
254-266	NULL
,	NULL
and	NULL
Bianchi	NULL
,	NULL
M.	NULL
,	NULL
Bloom	NULL
,	NULL
O.	NULL
,	NULL
Raabe	NULL
,	NULL
T.	NULL
,	NULL
Cohen	NULL
,	NULL
P.	NULL
S.	NULL
,	NULL
Chesney	NULL
,	NULL
J.	NULL
,	NULL
Sherry	NULL
,	NULL
B.	NULL
,	NULL
Schmidtmayerova	NULL
,	NULL
H.	NULL
,	NULL
Zhang	NULL
,	NULL
X.	NULL
,	NULL
Bukrinsky	NULL
,	NULL
M.	NULL
,	NULL
Ulrich	NULL
,	NULL
P.	NULL
,	NULL
Cerami	NULL
,	NULL
A	NULL
.	NULL

&	NULL
Tracey	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

,	NULL
in	NULL
press	NULL
]	NULL
.	NULL

We	NULL
have	NULL
now	NULL
elucidated	NULL
the	NULL
mechanism	NULL
by	NULL
which	NULL
CNI-1493	NULL
inhibits	NULL
macrophage	NULL
TNF	NULL
synthesis	NULL
and	NULL
show	NULL
here	NULL
that	NULL
it	NULL
acts	NULL
through	NULL
suppression	NULL
of	NULL
TNF	NULL
translation	NULL
efficiency	NULL
.	NULL

CNI-1493	NULL
blocked	NULL
neither	NULL
the	NULL
lipopolysaccharide	NULL
(	NULL
LPS	NULL
)	NULL
-induced	NULL
increases	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
TNF	NULL
mRNA	NULL
nor	NULL
the	NULL
translocation	NULL
of	NULL
nuclear	NULL
factor	NULL
NF-	NULL
«	NULL
B	NULL
to	NULL
the	NULL
nucleus	NULL
in	NULL
macrophages	NULL
activated	NULL
by	NULL
15	NULL
min	NULL
of	NULL
LPS	NULL
stimulation	NULL
,	NULL
indicating	NULL
that	NULL
CNI-1493	NULL
does	NULL
not	NULL
interfere	NULL
with	NULL
early	NULL
NF-KB-mediated	NULL
transcriptional	NULL
regulation	NULL
of	NULL
TNF	NULL
.	NULL

However	NULL
,	NULL
synthesis	NULL
of	NULL
the	NULL
26-kDa	NULL
membrane	NULL
form	NULL
of	NULL
TNF	NULL
was	NULL
effectively	NULL
blocked	NULL
by	NULL
CNI-1493	NULL
.	NULL

Further	NULL
evidence	NULL
for	NULL
the	NULL
translational	NULL
suppression	NULL
of	NULL
TNF	NULL
is	NULL
given	NULL
by	NULL
experiments	NULL
using	NULL
chloramphenicol	NULL
acetyltransferase	NULL
(	NULL
CAT	NULL
)	NULL
constructs	NULL
containing	NULL
elements	NULL
of	NULL
the	NULL
TNF	NULL
gene	NULL
that	NULL
are	NULL
involved	NULL
in	NULL
TNF	NULL
translational	NULL
regulation	NULL
.	NULL

Both	NULL
the	NULL
5	NULL
and	NULL
3	NULL
'	NULL
untranslated	NULL
regions	NULL
of	NULL
the	NULL
TNF	NULL
gene	NULL
were	NULL
required	NULL
to	NULL
elicit	NULL
maximal	NULL
translational	NULL
suppression	NULL
by	NULL
CNI-1493	NULL
.	NULL

Identification	NULL
of	NULL
the	NULL
molecular	NULL
target	NULL
through	NULL
which	NULL
CNI-1493	NULL
inhibits	NULL
TNF	NULL
translation	NULL
should	NULL
provide	NULL
insight	NULL
into	NULL
the	NULL
regulation	NULL
of	NULL
macrophage	NULL
activation	NULL
and	NULL
mechanisms	NULL
of	NULL
inflammation	NULL
.	NULL

Following	NULL
the	NULL
activation	NULL
of	NULL
monocytes	NULL
and	NULL
macrophages	NULL
,	NULL
the	NULL
rapid	NULL
production	NULL
of	NULL
proinflammatory	NULL
cytokines	NULL
[	NULL
such	NULL
as	NULL
tumor	NULL
necrosis	NULL
factor	NULL
(	NULL
TNF	NULL
)	NULL
,	NULL
interleukins	NULL
1	NULL
and	NULL
6	NULL
(	NULL
IL-1	NULL
and	NULL
IL-6	NULL
)	NULL
and	NULL
others	NULL
]	NULL
mediates	NULL
a	NULL
wide	NULL
variety	NULL
of	NULL
pathologic	NULL
states	NULL
,	NULL
including	NULL
lethal	NULL
shock	NULL
and	NULL
tissue	NULL
injury	NULL
,	NULL
acute	NULL
and	NULL
chronic	NULL
inflammation	NULL
,	NULL
and	NULL
cachexia	NULL
(	NULL
1	NULL
)	NULL
.	NULL

We	NULL
recently	NULL
described	NULL
a	NULL
tetravalent	NULL
guanylhydrazone	NULL
compound	NULL
(	NULL
CNI-1493	NULL
)	NULL
that	NULL
suppressed	NULL
lipopolysaccharide	NULL
(	NULL
LPS	NULL
)	NULL
-stimulated	NULL
macrophage	NULL
synthesis	NULL
of	NULL
proinflammatory	NULL
cytokines	NULL
[	NULL
TNF	NULL
,	NULL
IL-1	NULL
,	NULL
IL-6	NULL
,	NULL
macrophage	NULL
inflammatory	NULL
proteins	NULL
la	NULL
«	NULL
and	NULL
18	NULL
(	NULL
MIP-l1a	NULL
and	NULL
MIP-1	NULL
]	NULL
,	NULL
inhibited	NULL
the	NULL
synthesis	NULL
of	NULL
inducible	NULL
nitric	NULL
oxide	NULL
synthase	NULL
(	NULL
iNOS	NULL
)	NULL
,	NULL
and	NULL
protected	NULL
against	NULL
lethal	NULL
endotoxemia	NULL
and	NULL
carrageenan-induced	NULL
inflammation	NULL
in	NULL
mice	NULL
(	NULL
2	NULL
,	NULL
3	NULL
)	NULL
.	NULL

Previous	NULL
evidence	NULL
indicates	NULL
that	NULL
these	NULL
macrophage-suppressive	NULL
effects	NULL
were	NULL
selective	NULL
.	NULL

For	NULL
instance	NULL
,	NULL
concentrations	NULL
of	NULL
CNI-1493	NULL
that	NULL
completely	NULL
suppressed	NULL
TNF	NULL
protein	NULL
synthesis	NULL
did	NULL
not	NULL
suppress	NULL
total	NULL
cellular	NULL
RNA	NULL
transcription	NULL
as	NULL
measured	NULL
by	NULL
incorporation	NULL
of	NULL
The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

$	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

3967	NULL
labeled	NULL
uridine	NULL
into	NULL
total	NULL
RNA	NULL
and	NULL
did	NULL
not	NULL
suppress	NULL
total	NULL
cellular	NULL
protein	NULL
synthesis	NULL
as	NULL
measured	NULL
by	NULL
incorporation	NULL
of	NULL
labeled	NULL
methionine	NULL
into	NULL
total	NULL
protein	NULL
(	NULL
3	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
these	NULL
concentrations	NULL
of	NULL
CNI-1493	NULL
did	NULL
not	NULL
inhibit	NULL
enhanced	NULL
expression	NULL
of	NULL
major	NULL
histocompatibility	NULL
complex	NULL
(	NULL
MHC	NULL
)	NULL
class	NULL
II	NULL
antigens	NULL
mediated	NULL
by	NULL
y	NULL
interferon	NULL
(	NULL
IFN-y	NULL
)	NULL
(	NULL
3	NULL
)	NULL
.	NULL

By	NULL
contrast	NULL
with	NULL
glucocorticoids	NULL
,	NULL
another	NULL
class	NULL
of	NULL
inhibitors	NULL
that	NULL
suppresses	NULL
proinflammatory	NULL
cytokine	NULL
production	NULL
,	NULL
CNI-1493	NULL
retained	NULL
its	NULL
TNF-suppressive	NULL
effects	NULL
even	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IFN-y	NULL
.	NULL

TNF	NULL
synthesis	NULL
in	NULL
monocytes/macrophages	NULL
is	NULL
stimulated	NULL
by	NULL
LPS	NULL
and	NULL
other	NULL
invasive	NULL
stimuli	NULL
(	NULL
1	NULL
)	NULL
.	NULL

This	NULL
production	NULL
is	NULL
mediated	NULL
by	NULL
increases	NULL
in	NULL
the	NULL
transcription	NULL
and	NULL
translation	NULL
of	NULL
the	NULL
TNF	NULL
gene	NULL
(	NULL
4	NULL
)	NULL
.	NULL

Recent	NULL
evidence	NULL
suggests	NULL
that	NULL
discrete	NULL
signal	NULL
transduction	NULL
pathways	NULL
regulate	NULL
the	NULL
transcriptional	NULL
and	NULL
translational	NULL
regulatory	NULL
events	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

The	NULL
p38	NULL
MAP	NULL
kinase	NULL
signal	NULL
transduction	NULL
pathway	NULL
,	NULL
whose	NULL
intermediates	NULL
include	NULL
edc42	NULL
,	NULL
MEKK	NULL
,	NULL
MKK3/MKK4	NULL
,	NULL
and	NULL
p38	NULL
MAP	NULL
kinase	NULL
(	NULL
5-7	NULL
)	NULL
,	NULL
has	NULL
been	NULL
implicated	NULL
in	NULL
the	NULL
enhancement	NULL
of	NULL
TNF	NULL
translation	NULL
efficiency	NULL
after	NULL
LPS	NULL
stimulation	NULL
(	NULL
8-10	NULL
)	NULL
.	NULL

Transcriptional	NULL
activation	NULL
is	NULL
mediated	NULL
by	NULL
pathways	NULL
culminating	NULL
in	NULL
nuclear	NULL
translocation	NULL
of	NULL
the	NULL
transcriptional	NULL
regulator	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

In	NULL
these	NULL
cascades	NULL
,	NULL
LPS	NULL
stimulates	NULL
the	NULL
release	NULL
of	NULL
I-	NULL
«	NULL
B	NULL
from	NULL
cytoplasmic	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
resulting	NULL
in	NULL
translocation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
from	NULL
the	NULL
cytoplasm	NULL
to	NULL
the	NULL
nucleus	NULL
,	NULL
where	NULL
it	NULL
binds	NULL
«	NULL
B	NULL
consensus	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
promoters	NULL
of	NULL
target	NULL
genes	NULL
including	NULL
TNF	NULL
and	NULL
genes	NULL
of	NULL
other	NULL
proinflammatory	NULL
cytokines	NULL
(	NULL
11-13	NULL
)	NULL
.	NULL

In	NULL
the	NULL
present	NULL
investigation	NULL
,	NULL
we	NULL
determine	NULL
the	NULL
mechanism	NULL
by	NULL
which	NULL
CNI-1493	NULL
suppresses	NULL
TNF	NULL
protein	NULL
synthesis	NULL
.	NULL

The	NULL
results	NULL
now	NULL
indicate	NULL
that	NULL
CNI-1493	NULL
acts	NULL
by	NULL
inhibiting	NULL
TNF	NULL
translational	NULL
efficiency	NULL
and	NULL
not	NULL
by	NULL
inhibiting	NULL
the	NULL
nuclear	NULL
translocation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
LPS-stimulated	NULL
macrophages	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cell	NULL
Isolation	NULL
and	NULL
Culture	NULL
.	NULL

For	NULL
studies	NULL
of	NULL
human	NULL
mono-cytes	NULL
,	NULL
buffy	NULL
coats	NULL
were	NULL
obtained	NULL
by	NULL
elutriation	NULL
from	NULL
normal	NULL
individual	NULL
donors	NULL
to	NULL
the	NULL
Long	NULL
Island	NULL
Blood	NULL
Bank	NULL
Services	NULL
.	NULL

Peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
(	NULL
PBMCs	NULL
)	NULL
were	NULL
isolated	NULL
by	NULL
density-gradient	NULL
centrifugation	NULL
through	NULL
Ficoll/Hypaque	NULL
(	NULL
Pharmacia	NULL
)	NULL
;	NULL
typically	NULL
one	NULL
preparation	NULL
yielded	NULL
200	NULL
x	NULL
10°	NULL
adherent	NULL
cells	NULL
.	NULL

These	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
100-mm	NULL
plates	NULL
at	NULL
2	NULL
X	NULL
10°	NULL
cells	NULL
per	NULL
plate	NULL
in	NULL
5	NULL
ml	NULL
of	NULL
RPMI	NULL
1640	NULL
medium	NULL
containing	NULL
10	NULL
%	NULL
(	NULL
vol/vol	NULL
)	NULL
normal	NULL
heat-inactivated	NULL
human	NULL
serum	NULL
,	NULL
antibiotics	NULL
,	NULL
and	NULL
L-glutamine	NULL
.	NULL

Cells	NULL
were	NULL
allowed	NULL
to	NULL
adhere	NULL
overnight	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
5	NULL
%	NULL
CO	NULL
;	NULL
in	NULL
a	NULL
humidified	NULL
incubator	NULL
at	NULL
37°C	NULL
.	NULL

Nonadherent	NULL
cells	NULL
were	NULL
washed	NULL
away	NULL
twice	NULL
with	NULL
phosphate-buffered	NULL
saline	NULL
(	NULL
PBS	NULL
)	NULL
,	NULL
and	NULL
adherent	NULL
cells	NULL
(	NULL
monocytes	NULL
)	NULL
were	NULL
then	NULL
treated	NULL
with	NULL
CNI-1493	NULL
at	NULL
1	NULL
LM	NULL
Abbreviations	NULL
:	NULL
PBMC	NULL
,	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cell	NULL
;	NULL
CMV	NULL
,	NULL
cytomegalovirus	NULL
;	NULL
TNF	NULL
,	NULL
tumor	NULL
necrosis	NULL
factor	NULL
;	NULL
LPS	NULL
,	NULL
lipopolysaccha-ride	NULL
;	NULL
CAT	NULL
,	NULL
chloramphenicol	NULL
acetyltransferase	NULL
;	NULL
IL-1	NULL
and	NULL
IL-6	NULL
,	NULL
interleukins	NULL
1	NULL
and	NULL
6	NULL
;	NULL
MAP	NULL
kinase	NULL
,	NULL
mitogen-activated	NULL
kinase	NULL
;	NULL
MIP	NULL
,	NULL
macrophage	NULL
inflammatory	NULL
protein	NULL
;	NULL
iNOS	NULL
,	NULL
inducible	NULL
nitric	NULL
oxide	NULL
synthase	NULL
;	NULL
IFN-y	NULL
,	NULL
y	NULL
interferon	NULL
;	NULL
MHC	NULL
,	NULL
major	NULL
histocompatibility	NULL
complex	NULL
;	NULL
UTR	NULL
,	NULL
untranslated	NULL
region	NULL
.	NULL

3968	NULL
Medical	NULL
Sciences	NULL
:	NULL
Cohen	NULL
et	NULL
al	NULL
.	NULL

LPS	NULL
»	NULL
-	NULL
MACROPHAGE	NULL
ACTIVATION	NULL
MKK3/MKK4	NULL
p38	NULL
MAPK	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

-	NULL
Schematic	NULL
illustration	NULL
of	NULL
putative	NULL
signal	NULL
transduction	NULL
pathways	NULL
regulating	NULL
the	NULL
macrophage	NULL
activation-mediated	NULL
production	NULL
of	NULL
TNF	NULL
.	NULL

MAPK	NULL
,	NULL
mitogen-activated	NULL
protein	NULL
(	NULL
MAP	NULL
)	NULL
kinase	NULL
.	NULL

for	NULL
various	NULL
periods	NULL
of	NULL
time	NULL
,	NULL
followed	NULL
by	NULL
stimulation	NULL
with	NULL
LPS	NULL
(	NULL
Escherichia	NULL
coli	NULL
0111	NULL
:	NULL
B4	NULL
,	NULL
100	NULL
ng/ml	NULL
;	NULL
Sigma	NULL
)	NULL
for	NULL
either	NULL
2	NULL
hr	NULL
(	NULL
for	NULL
RNA	NULL
studies	NULL
)	NULL
or	NULL
4	NULL
hr	NULL
(	NULL
for	NULL
protein	NULL
studies	NULL
)	NULL
.	NULL

The	NULL
murine	NULL
macrophage-like	NULL
RAW	NULL
264.7	NULL
cells	NULL
[	NULL
obtained	NULL
from	NULL
the	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
(	NULL
ATCC	NULL
)	NULL
,	NULL
Rockville	NULL
,	NULL
MD	NULL
]	NULL
were	NULL
maintained	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
containing	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
FCS	NULL
)	NULL
,	NULL
antibiotics	NULL
,	NULL
and	NULL
L-glutamine	NULL
.	NULL

Cells	NULL
were	NULL
allowed	NULL
to	NULL
adhere	NULL
for	NULL
4	NULL
hr	NULL
prior	NULL
to	NULL
use	NULL
in	NULL
experiments	NULL
.	NULL

Total	NULL
RNA	NULL
Isolation	NULL
and	NULL
Quantitation	NULL
of	NULL
TNF	NULL
mRNA	NULL
Levels	NULL
.	NULL

Total	NULL
RNA	NULL
was	NULL
prepared	NULL
from	NULL
primary	NULL
PBMCs	NULL
treated	NULL
with	NULL
LPS	NULL
at	NULL
100	NULL
ng/ml	NULL
with	NULL
or	NULL
without	NULL
1	NULL
wM	NULL
CNI-1493	NULL
and/or	NULL
5	NULL
ug	NULL
of	NULL
actinomycin	NULL
D	NULL
per	NULL
ml	NULL
for	NULL
0	NULL
,	NULL
20	NULL
,	NULL
or	NULL
40	NULL
min	NULL
by	NULL
using	NULL
the	NULL
RNAzol	NULL
B	NULL
reagent	NULL
(	NULL
Tel-Test	NULL
,	NULL
Friendswood	NULL
,	NULL
TX	NULL
)	NULL
per	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
.	NULL

Competitive	NULL
reverse	NULL
transcription	NULL
(	NULL
RT	NULL
)	NULL
-PCR	NULL
methods	NULL
were	NULL
used	NULL
to	NULL
quantitate	NULL
TNF	NULL
mRNA	NULL
levels	NULL
(	NULL
14	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
one	NULL
set	NULL
of	NULL
oligonucleotide	NULL
primers	NULL
was	NULL
used	NULL
to	NULL
amplify	NULL
both	NULL
endogenous	NULL
TNF	NULL
cDNA	NULL
and	NULL
exogenously	NULL
added	NULL
artificial	NULL
TNF-MIMIC	NULL
DNA	NULL
of	NULL
known	NULL
concentration	NULL
.	NULL

MIMIC	NULL
template	NULL
was	NULL
constructed	NULL
with	NULL
the	NULL
use	NULL
of	NULL
a	NULL
PCR-MIMIC	NULL
construction	NULL
kit	NULL
(	NULL
Clontech	NULL
)	NULL
following	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
.	NULL

Primer	NULL
pairs	NULL
used	NULL
for	NULL
MIMIC	NULL
synthesis	NULL
were	NULL
S	NULL
'	NULL
!	NULL

-ACTGAAAGCATGATCCGGGACCGCAAGT-GAAATCTCCTCCG-3	NULL
'	NULL
and	NULL
5'-TCACAGGGCAATGATC-CCAAATCTGTCAATGCAGTTGTGAG-3	NULL
'	NULL
.	NULL

Primers	NULL
used	NULL
for	NULL
RT-PCR	NULL
of	NULL
both	NULL
TNF-MIMIC	NULL
and	NULL
endogenous	NULL
TNF	NULL
mRNA	NULL
were	NULL
:	NULL
5-ACTGAAAGCATGATCCGGGAC-3	NULL
'	NULL
(	NULL
spanning	NULL
TNF	NULL
base	NULL
pairs	NULL
92-112	NULL
)	NULL
and	NULL
5'-TCACAGGGC-AATG-ATCCCAAA-3	NULL
'	NULL
(	NULL
spanning	NULL
TNF	NULL
base	NULL
pairs	NULL
766-787	NULL
)	NULL
,	NULL
which	NULL
yielded	NULL
a	NULL
695-bp	NULL
fragment	NULL
from	NULL
endogenous	NULL
TNF	NULL
mRNA	NULL
and	NULL
a	NULL
450-bp	NULL
TNF-MIMIC	NULL
fragment	NULL
(	NULL
15	NULL
)	NULL
.	NULL

RT-PCR	NULL
was	NULL
performed	NULL
by	NULL
using	NULL
the	NULL
Perkin-Elmer	NULL
RT-PCR	NULL
kit	NULL
as	NULL
per	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
with	NULL
the	NULL
following	NULL
modifica-tions	NULL
:	NULL
(	NULL
¢	NULL
)	NULL
0.35	NULL
ug	NULL
of	NULL
RNA	NULL
was	NULL
used	NULL
per	NULL
reaction	NULL
,	NULL
(	NULL
if	NULL
)	NULL
the	NULL
RT	NULL
reaction	NULL
was	NULL
primed	NULL
with	NULL
random	NULL
hexamers	NULL
,	NULL
(	NULL
ii	NULL
?	NULL
)	NULL

the	NULL
PCR	NULL
reaction	NULL
was	NULL
amplified	NULL
for	NULL
30	NULL
cycles	NULL
,	NULL
and	NULL
the	NULL
(	NULL
iv	NULL
)	NULL
PCR	NULL
reaction	NULL
was	NULL
adjusted	NULL
to	NULL
contain	NULL
2.5	NULL
mg	NULL
of	NULL
MgCl	NULL
;	NULL
per	NULL
ml	NULL
.	NULL

The	NULL
PCR	NULL
cycle	NULL
consisted	NULL
of	NULL
95°C	NULL
for	NULL
15	NULL
sec	NULL
,	NULL
55°C	NULL
for	NULL
30	NULL
sec	NULL
,	NULL
and	NULL
65°C	NULL
for	NULL
60	NULL
sec	NULL
.	NULL

After	NULL
the	NULL
final	NULL
amplification	NULL
,	NULL
the	NULL
reaction	NULL
was	NULL
elongated	NULL
for	NULL
7	NULL
min	NULL
at	NULL
72°C	NULL
.	NULL

Twenty	NULL
microliters	NULL
of	NULL
each	NULL
reaction	NULL
mixture	NULL
was	NULL
separated	NULL
by	NULL
electrophoresis	NULL
by	NULL
using	NULL
1.5	NULL
%	NULL
agarose	NULL
gels	NULL
,	NULL
followed	NULL
by	NULL
staining	NULL
with	NULL
ethidium	NULL
bro-mide	NULL
.	NULL

The	NULL
quantity	NULL
of	NULL
TNF	NULL
cDNA	NULL
in	NULL
a	NULL
given	NULL
reaction	NULL
sample	NULL
was	NULL
measured	NULL
by	NULL
extrapolating	NULL
from	NULL
serial	NULL
dilutions	NULL
of	NULL
TNF-MIMIC	NULL
in	NULL
the	NULL
same	NULL
reaction	NULL
.	NULL

Electrophoretic	NULL
Mobility	NULL
Shift	NULL
Assay	NULL
.	NULL

RAW	NULL
264.7	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
CNI-1493	NULL
at	NULL
various	NULL
concentrations	NULL
and	NULL
stimu-	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
93	NULL
(	NULL
1996	NULL
)	NULL
lated	NULL
with	NULL
100	NULL
ng	NULL
of	NULL
LPS	NULL
per	NULL
ml	NULL
for	NULL
15	NULL
min	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
rinsed	NULL
in	NULL
ice-cold	NULL
PBS	NULL
and	NULL
harvested	NULL
.	NULL

Extracts	NULL
were	NULL
prepared	NULL
essentially	NULL
as	NULL
described	NULL
(	NULL
16	NULL
)	NULL
and	NULL
incubated	NULL
with	NULL
*°P-labeled	NULL
oligodeoxynucleotides	NULL
corresponding	NULL
to	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
consensus	NULL
binding	NULL
site	NULL
(	NULL
Promega	NULL
)	NULL
.	NULL

Binding	NULL
reactions	NULL
and	NULL
electrophoresis	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
(	NULL
16	NULL
)	NULL
.	NULL

TNF	NULL
Pulse	NULL
Labeling	NULL
.	NULL

Newly	NULL
synthesized	NULL
proteins	NULL
were	NULL
radiolabeled	NULL
by	NULL
using	NULL
a	NULL
modified	NULL
version	NULL
of	NULL
previously	NULL
described	NULL
methods	NULL
(	NULL
17	NULL
,	NULL
18	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
human	NULL
PBMCs	NULL
isolated	NULL
by	NULL
elutriation	NULL
and	NULL
purified	NULL
by	NULL
adherence	NULL
were	NULL
incubated	NULL
overnight	NULL
in	NULL
Dulbecco	NULL
's	NULL
modified	NULL
Eagle	NULL
's	NULL
medium	NULL
containing	NULL
10	NULL
%	NULL
FCS	NULL
,	NULL
antibiotics	NULL
,	NULL
and	NULL
L-glutamine	NULL
without	NULL
methionine	NULL
and	NULL
were	NULL
treated	NULL
with	NULL
CNI-1493	NULL
in	NULL
concentrations	NULL
shown	NULL
.	NULL

After	NULL
1	NULL
hr	NULL
,	NULL
the	NULL
medium	NULL
was	NULL
replaced	NULL
with	NULL
fresh	NULL
methionine-free	NULL
medium	NULL
containing	NULL
0.2	NULL
mCi	NULL
of	NULL
[	NULL
**S	NULL
)	NULL
methi-onine	NULL
(	NULL
NEN	NULL
)	NULL
and	NULL
100	NULL
ng	NULL
of	NULL
LPS	NULL
per	NULL
ml	NULL
for	NULL
1	NULL
hr	NULL
.	NULL

The	NULL
pulse-labeling	NULL
period	NULL
was	NULL
terminated	NULL
by	NULL
removing	NULL
the	NULL
culture	NULL
medium	NULL
,	NULL
washing	NULL
the	NULL
cells	NULL
twice	NULL
with	NULL
PBS	NULL
,	NULL
and	NULL
adding	NULL
methionine-containing	NULL
medium	NULL
.	NULL

Cells	NULL
were	NULL
lysed	NULL
in	NULL
buffer	NULL
[	NULL
50	NULL
mM	NULL
Tris-HCl	NULL
,	NULL
pH	NULL
7.4/100	NULL
mM	NULL
NaCl/1	NULL
%	NULL
Triton	NULL
X-100/5	NULL
mM	NULL
EDTA/0.02	NULL
%	NULL
sodium	NULL
azide/100	NULL
uM	NULL
phenylmethylsul-fonyl	NULL
fluoride	NULL
(	NULL
PMSF	NULL
)	NULL
/1	NULL
uM	NULL
pepstatin	NULL
]	NULL
;	NULL
50	NULL
ul	NULL
of	NULL
10	NULL
%	NULL
lysis	NULL
buffer	NULL
was	NULL
added	NULL
per	NULL
500-ul	NULL
supernatants	NULL
.	NULL

Cell	NULL
lysates	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
polyclonal	NULL
rabbit	NULL
anti-human	NULL
TNF	NULL
(	NULL
from	NULL
Barbara	NULL
Sherry	NULL
,	NULL
Picower	NULL
Institute	NULL
)	NULL
,	NULL
collected	NULL
over	NULL
protein	NULL
A-agarose	NULL
beads	NULL
,	NULL
and	NULL
analyzed	NULL
by	NULL
SDS/PAGE	NULL
electrophoresis	NULL
and	NULL
autoradiography	NULL
.	NULL

Chloramphenicol	NULL
Acetyltransferase	NULL
(	NULL
CAT	NULL
)	NULL
Assay	NULL
.	NULL

Plasmid	NULL
constructs	NULL
containing	NULL
the	NULL
CAT	NULL
gene	NULL
and	NULL
either	NULL
elements	NULL
of	NULL
the	NULL
human	NULL
TNF	NULL
3	NULL
'	NULL
untranslated	NULL
region	NULL
downstream	NULL
(	NULL
3	NULL
'	NULL
UTR	NULL
)	NULL
,	NULL
the	NULL
5	NULL
'	NULL
untranslated	NULL
region	NULL
(	NULL
5	NULL
'	NULL
UTR	NULL
)	NULL
,	NULL
both	NULL
5	NULL
and	NULL
3	NULL
'	NULL
fragments	NULL
(	NULL
5	NULL
'	NULL
UTR-3	NULL
'	NULL
UTR	NULL
)	NULL
,	NULL
or	NULL
the	NULL
cytomegalovirus	NULL
(	NULL
CMV	NULL
)	NULL
promoter	NULL
were	NULL
generous	NULL
gifts	NULL
of	NULL
Bruce	NULL
Beutler	NULL
(	NULL
University	NULL
of	NULL
Texas	NULL
Southwestern	NULL
Medical	NULL
Center	NULL
,	NULL
Dallas	NULL
)	NULL
.	NULL

Through	NULL
use	NULL
of	NULL
these	NULL
reporter	NULL
constructs	NULL
,	NULL
both	NULL
the	NULL
3	NULL
'	NULL
and	NULL
5	NULL
'	NULL
UTR	NULL
regions	NULL
of	NULL
the	NULL
TNF	NULL
gene	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
contribute	NULL
to	NULL
the	NULL
regulation	NULL
of	NULL
TNF	NULL
biosynthesis	NULL
at	NULL
the	NULL
translational	NULL
level	NULL
(	NULL
19-21	NULL
)	NULL
.	NULL

CAT	NULL
construct	NULL
(	NULL
2-10	NULL
ug	NULL
of	NULL
DNA	NULL
)	NULL
was	NULL
cotransfected	NULL
into	NULL
RAW	NULL
264.7	NULL
cells	NULL
with	NULL
2	NULL
ug	NULL
of	NULL
plasmid	NULL
pCH110	NULL
containing	NULL
the	NULL
B-galactosidase	NULL
gene	NULL
under	NULL
the	NULL
control	NULL
of	NULL
the	NULL
simian	NULL
virus	NULL
40	NULL
promoter	NULL
(	NULL
Pharmacia	NULL
)	NULL
,	NULL
which	NULL
was	NULL
included	NULL
as	NULL
an	NULL
internal	NULL
control	NULL
for	NULL
transfection	NULL
efficiency	NULL
.	NULL

Transfections	NULL
were	NULL
performed	NULL
by	NULL
a	NULL
calcium	NULL
phosphate	NULL
precipitation	NULL
method	NULL
(	NULL
22	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
washed	NULL
24	NULL
and	NULL
48	NULL
hr	NULL
later	NULL
with	NULL
medium	NULL
,	NULL
treated	NULL
with	NULL
1	NULL
mM	NULL
CNI-1493	NULL
for	NULL
1	NULL
hr	NULL
where	NULL
indicated	NULL
and	NULL
then	NULL
exposed	NULL
to	NULL
LPS	NULL
at	NULL
1	NULL
ug/ml	NULL
.	NULL

After	NULL
four	NULL
hours	NULL
,	NULL
cell	NULL
lysates	NULL
were	NULL
harvested	NULL
for	NULL
determination	NULL
of	NULL
both	NULL
B-galactosidase	NULL
and	NULL
CAT	NULL
activity	NULL
.	NULL

B-galactosidase	NULL
activity	NULL
was	NULL
photometrically	NULL
assayed	NULL
by	NULL
measuring	NULL
the	NULL
conversion	NULL
of	NULL
o-nitrophenyl	NULL
B-D-galactopyranoside	NULL
(	NULL
23	NULL
)	NULL
.	NULL

CAT	NULL
assays	NULL
were	NULL
performed	NULL
by	NULL
using	NULL
25	NULL
unit	NULL
equivalents	NULL
of	NULL
-galactosidase	NULL
per	NULL
TLC	NULL
assay	NULL
according	NULL
to	NULL
the	NULL
method	NULL
of	NULL
Gorman	NULL
and	NULL
others	NULL
(	NULL
24	NULL
)	NULL
.	NULL

CAT	NULL
results	NULL
were	NULL
imaged	NULL
and	NULL
quantitated	NULL
on	NULL
a	NULL
phosphorimager	NULL
(	NULL
Packard	NULL
Instantimager	NULL
)	NULL
;	NULL
TLC	NULL
plates	NULL
were	NULL
also	NULL
exposed	NULL
to	NULL
Kodak	NULL
XAR	NULL
film	NULL
.	NULL

All	NULL
experiments	NULL
were	NULL
performed	NULL
in	NULL
triplicate	NULL
.	NULL

RESULTS	NULL
CNI-1493	NULL
Does	NULL
Not	NULL
Suppress	NULL
Increased	NULL
Expression	NULL
of	NULL
TNF	NULL
mRNA	NULL
.	NULL

In	NULL
agreement	NULL
with	NULL
previous	NULL
results	NULL
(	NULL
2	NULL
)	NULL
,	NULL
we	NULL
found	NULL
that	NULL
addition	NULL
of	NULL
1	NULL
uM	NULL
CNI-1493	NULL
to	NULL
PBMCs	NULL
suppressed	NULL
95	NULL
%	NULL
of	NULL
secreted	NULL
TNF	NULL
protein	NULL
measured	NULL
by	NULL
ELISA	NULL
in	NULL
super-natants	NULL
collected	NULL
4	NULL
hr	NULL
after	NULL
LPS	NULL
stimulation	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

To	NULL
evaluate	NULL
whether	NULL
CNI-1493	NULL
inhibited	NULL
TNF	NULL
via	NULL
suppression	NULL
of	NULL
transcriptional	NULL
regulation	NULL
,	NULL
steady-state	NULL
TNF	NULL
mRNA	NULL
levels	NULL
were	NULL
measured	NULL
in	NULL
LPS-activated	NULL
PBMCs	NULL
by	NULL
using	NULL
the	NULL
method	NULL
of	NULL
quantitative	NULL
RT-PCR	NULL
.	NULL

TNF	NULL
mRNA	NULL
was	NULL
observed	NULL
to	NULL
increase	NULL
nearly	NULL
one	NULL
million-fold	NULL
within	NULL
2	NULL
hr	NULL
after	NULL
LPS	NULL
activation	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Addition	NULL
of	NULL
CNI-1493	NULL
in	NULL
quantities	NULL
that	NULL
suppressed	NULL
95	NULL
%	NULL
of	NULL
secreted	NULL
TNF	NULL
protein	NULL
(	NULL
1	NULL
wM	NULL
)	NULL
in	NULL
Medical	NULL
Sciences	NULL
:	NULL
Cohen	NULL
et	NULL
al	NULL
.	NULL

these	NULL
experiments	NULL
did	NULL
not	NULL
significantly	NULL
reduce	NULL
the	NULL
increased	NULL
expression	NULL
of	NULL
TNF	NULL
mRNA	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

We	NULL
observed	NULL
a	NULL
modest	NULL
reduction	NULL
in	NULL
peak	NULL
steady-state	NULL
level	NULL
of	NULL
TNF	NULL
mRNA	NULL
,	NULL
which	NULL
was	NULL
attributable	NULL
to	NULL
decreased	NULL
TNF	NULL
mRNA	NULL
stability	NULL
,	NULL
measured	NULL
by	NULL
treating	NULL
PBMCs	NULL
with	NULL
LPS	NULL
and	NULL
CNI-1493	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
actinomycin	NULL
D	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
these	NULL
data	NULL
give	NULL
evidence	NULL
that	NULL
the	NULL
suppressive	NULL
effect	NULL
of	NULL
CNI-1493	NULL
on	NULL
TNF	NULL
protein	NULL
production	NULL
can	NULL
not	NULL
be	NULL
due	NULL
to	NULL
suppression	NULL
of	NULL
TNF	NULL
mRNA	NULL
expression	NULL
.	NULL

CNI-1493	NULL
Does	NULL
Not	NULL
Inhibit	NULL
Nuclear	NULL
Translocation	NULL
of	NULL
NF-xB	NULL
During	NULL
Early	NULL
Macrophage	NULL
Activation	NULL
.	NULL

Because	NULL
CNI-1493	NULL
did	NULL
not	NULL
interfere	NULL
with	NULL
LPS-induced	NULL
up-regulation	NULL
of	NULL
TNF	NULL
mRNA	NULL
,	NULL
these	NULL
results	NULL
predicted	NULL
that	NULL
CNI-1493	NULL
would	NULL
not	NULL
suppress	NULL
the	NULL
early	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
a	NULL
transcriptional	NULL
activator	NULL
of	NULL
TNF	NULL
(	NULL
13	NULL
,	NULL
25	NULL
,	NULL
26	NULL
)	NULL
.	NULL

Accordingly	NULL
,	NULL
the	NULL
electrophoretic	NULL
mobility-shift	NULL
assay	NULL
was	NULL
utilized	NULL
to	NULL
address	NULL
this	NULL
hypothesis	NULL
.	NULL

Addition	NULL
of	NULL
CNI-1493	NULL
at	NULL
concentrations	NULL
that	NULL
inhibit	NULL
50	NULL
%	NULL
and	NULL
95	NULL
%	NULL
of	NULL
TNF	NULL
protein	NULL
(	NULL
0.5	NULL
and	NULL
1	NULL
uM	NULL
,	NULL
respectively	NULL
)	NULL
did	NULL
not	NULL
inhibit	NULL
the	NULL
nuclear	NULL
translocation	NULL
of	NULL
NF-kB	NULL
following	NULL
LPS	NULL
stimulation	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
CNI-1493	NULL
failed	NULL
to	NULL
inhibit	NULL
the	NULL
early	NULL
NF-	NULL
«	NULL
B	NULL
signal	NULL
transduction	NULL
pathways	NULL
activated	NULL
within	NULL
15	NULL
min	NULL
after	NULL
LPS	NULL
treatment	NULL
and	NULL
allowed	NULL
increased	NULL
expression	NULL
transcription	NULL
of	NULL
TNF	NULL
mRNA	NULL
.	NULL

CNI-1493	NULL
Inhibits	NULL
Synthesis	NULL
of	NULL
Membrane-Bound	NULL
TNF	NULL
(	NULL
26	NULL
kDa	NULL
)	NULL
.	NULL

To	NULL
address	NULL
directly	NULL
CNI-1493	NULL
inhibition	NULL
of	NULL
TNF	NULL
protein	NULL
translation	NULL
,	NULL
we	NULL
used	NULL
[	NULL
°°S	NULL
)	NULL
Jmethionine	NULL
labeling	NULL
and	NULL
immunoprecipitation	NULL
to	NULL
determine	NULL
the	NULL
effect	NULL
of	NULL
CNI-1493	NULL
on	NULL
the	NULL
translation	NULL
of	NULL
the	NULL
26-kDa	NULL
membrane	NULL
TNF	NULL
prohormone	NULL
(	NULL
17	NULL
)	NULL
.	NULL

CNI-1493	NULL
effectively	NULL
suppressed	NULL
the	NULL
synthesis	NULL
of	NULL
the	NULL
26-kDa	NULL
prohormone	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

Because	NULL
the	NULL
26-kDa	NULL
prohormone	NULL
is	NULL
the	NULL
precursor	NULL
to	NULL
mature	NULL
17-kDa	NULL
TNF	NULL
,	NULL
inhibition	NULL
of	NULL
26-kDa	NULL
protein	NULL
translation	NULL
thereby	NULL
prevented	NULL
appearance	NULL
of	NULL
the	NULL
17-kDa	NULL
form	NULL
as	NULL
well	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

Since	NULL
LPS	NULL
stimulation	NULL
normally	NULL
increases	NULL
the	NULL
translational	NULL
efficiency	NULL
of	NULL
the	NULL
26-kDa	NULL
TNF	NULL
(	NULL
17	NULL
)	NULL
,	NULL
these	NULL
results	NULL
indicate	NULL
that	NULL
CNI-1493	NULL
suppresses	NULL
TNF	NULL
production	NULL
by	NULL
inhibiting	NULL
the	NULL
translational	NULL
activation	NULL
of	NULL
26-kDa	NULL
TNF	NULL
.	NULL

CNI-1493	NULL
Suppresses	NULL
TNF	NULL
Translation	NULL
Through	NULL
Both	NULL
5	NULL
and	NULL
3	NULL
'	NULL
UTRs	NULL
of	NULL
TNF	NULL
.	NULL

It	NULL
has	NULL
previously	NULL
been	NULL
shown	NULL
that	NULL
elements	NULL
in	NULL
both	NULL
the	NULL
5	NULL
'	NULL
and	NULL
the	NULL
3	NULL
'	NULL
UTRs	NULL
of	NULL
the	NULL
TNF	NULL
gene	NULL
A	NULL
1°	NULL
$	NULL
--	NULL
-¥	NULL
5	NULL
102	NULL
‘	NULL
°	NULL
’	NULL
\\	NULL
‘	NULL
\~\T	NULL
103	NULL
104	NULL
105	NULL
108	NULL
TNF	NULL
mRNA	NULL
{	NULL
attamoles/0.35	NULL
pg	NULL
total	NULL
mRNA	NULL
)	NULL
108	NULL
|	NULL
r	NULL
t	NULL
H	NULL
0	NULL
120	NULL
140	NULL
160	NULL
Time	NULL
after	NULL
LPS	NULL
(	NULL
minutes	NULL
)	NULL
FiG	NULL
.	NULL

2	NULL
.	NULL

Quantitation	NULL
of	NULL
steady-state	NULL
TNF	NULL
mRNA	NULL
levels	NULL
in	NULL
human	NULL
PBMCs	NULL
.	NULL

Human	NULL
PBMCs	NULL
were	NULL
harvested	NULL
for	NULL
total	NULL
mRNA	NULL
,	NULL
and	NULL
TNF	NULL
mRNA	NULL
levels	NULL
were	NULL
quantitated	NULL
by	NULL
using	NULL
competitive	NULL
RT-PCR	NULL
as	NULL
described	NULL
in	NULL
text	NULL
.	NULL

TNF	NULL
mRNA	NULL
was	NULL
assayed	NULL
in	NULL
the	NULL
unstimulated	NULL
state	NULL
(	NULL
®	NULL
)	NULL
,	NULL
after	NULL
2	NULL
hr	NULL
of	NULL
LPS	NULL
treatment	NULL
at	NULL
100	NULL
ng/ml	NULL
(	NULL
v	NULL
)	NULL
and	NULL
after	NULL
1-hr	NULL
pretreatment	NULL
with	NULL
1	NULL
uM	NULL
CNI-1493	NULL
followed	NULL
by	NULL
2	NULL
hr	NULL
of	NULL
LPS	NULL
treatment	NULL
(	NULL
)	NULL
.	NULL

Half-life	NULL
studies	NULL
were	NULL
performed	NULL
by	NULL
treating	NULL
PBMCs	NULL
as	NULL
above	NULL
with	NULL
addition	NULL
of	NULL
actinomycin	NULL
D	NULL
at	NULL
5	NULL
ug/ml	NULL
prior	NULL
to	NULL
mRNA	NULL
harvest	NULL
.	NULL

Time	NULL
points	NULL
shown	NULL
are	NULL
after	NULL
addition	NULL
of	NULL
LPS	NULL
;	NULL
actinomycin	NULL
D	NULL
was	NULL
added	NULL
at	NULL
120	NULL
min	NULL
.	NULL

Data	NULL
are	NULL
expressed	NULL
as	NULL
the	NULL
mean	NULL
+	NULL
SD	NULL
(	NULL
n	NULL
=	NULL
3	NULL
experiments	NULL
)	NULL
;	NULL
where	NULL
error	NULL
bars	NULL
are	NULL
not	NULL
visible	NULL
,	NULL
they	NULL
lie	NULL
within	NULL
the	NULL
symbol	NULL
itself	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
93	NULL
(	NULL
1996	NULL
)	NULL
3969	NULL
NF-kB	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

Effect	NULL
of	NULL
CNI-1493	NULL
on	NULL
LPS-induced	NULL
NF-KB	NULL
activation	NULL
in	NULL
RAW	NULL
264.7	NULL
cells	NULL
.	NULL

RAW	NULL
264.7	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
CNI-1493	NULL
at	NULL
various	NULL
concentrations	NULL
for	NULL
1	NULL
hr	NULL
as	NULL
indicated	NULL
.	NULL

Cells	NULL
were	NULL
stimulated	NULL
with	NULL
LPS	NULL
at	NULL
100	NULL
ng/ml	NULL
for	NULL
15	NULL
min	NULL
.	NULL

Whole-cell	NULL
lysates	NULL
were	NULL
prepared	NULL
and	NULL
analyzed	NULL
for	NULL
NF-kB	NULL
binding	NULL
activity	NULL
as	NULL
described	NULL
in	NULL
text	NULL
.	NULL

contribute	NULL
to	NULL
the	NULL
enhanced	NULL
translational	NULL
efficiency	NULL
of	NULL
TNF	NULL
mRNA	NULL
in	NULL
monocytes/macrophages	NULL
after	NULL
LPS	NULL
stimulation	NULL
(	NULL
19	NULL
,	NULL
20	NULL
,	NULL
27	NULL
)	NULL
.	NULL

We	NULL
used	NULL
these	NULL
same	NULL
CAT	NULL
plasmid	NULL
constructs	NULL
to	NULL
address	NULL
whether	NULL
the	NULL
suppressive	NULL
effect	NULL
of	NULL
CNI-1493	NULL
on	NULL
TNF	NULL
protein	NULL
translation	NULL
depended	NULL
on	NULL
the	NULL
presence	NULL
of	NULL
either	NULL
or	NULL
both	NULL
of	NULL
these	NULL
elements	NULL
.	NULL

In	NULL
agreement	NULL
with	NULL
previous	NULL
work	NULL
(	NULL
19	NULL
,	NULL
20	NULL
,	NULL
27	NULL
)	NULL
,	NULL
transfection	NULL
of	NULL
RAW	NULL
264.7	NULL
cells	NULL
with	NULL
the	NULL
3	NULL
'	NULL
UTR	NULL
,	NULL
5	NULL
'	NULL
UTR	NULL
,	NULL
and	NULL
5	NULL
UTR-3	NULL
'	NULL
UTR	NULL
construct	NULL
suppressed	NULL
expression	NULL
of	NULL
CAT	NULL
as	NULL
compared	NULL
with	NULL
transfections	NULL
with	NULL
CMV-CAT	NULL
constructs	NULL
not	NULL
containing	NULL
TNF	NULL
elements	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
and	NULL
addition	NULL
of	NULL
LPS	NULL
significantly	NULL
stimulated	NULL
CAT	NULL
reporter	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

Addition	NULL
of	NULL
1	NULL
wM	NULL
CNI-1493	NULL
suppressed	NULL
CAT	NULL
reporter	NULL
biosynthesis	NULL
in	NULL
LPS-treated	NULL
cells	NULL
containing	NULL
either	NULL
the	NULL
5	NULL
'	NULL
UTR	NULL
,	NULL
the	NULL
3	NULL
'	NULL
UTR	NULL
,	NULL
or	NULL
the	NULL
5°	NULL
UTR-3	NULL
'	NULL
UTR	NULL
constructs	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

Average	NULL
suppression	NULL
of	NULL
LPS-mediated	NULL
CAT	NULL
biosynthesis	NULL
for	NULL
the	NULL
different	NULL
constructs	NULL
we	NULL
observed	NULL
was	NULL
:	NULL
5	NULL
UTR	NULL
(	NULL
24	NULL
+	NULL
2	NULL
%	NULL
,	NULL
n	NULL
=	NULL
3	NULL
)	NULL
,	NULL
3°	NULL
UTR	NULL
(	NULL
24	NULL
+	NULL
17	NULL
%	NULL
,	NULL
n	NULL
=	NULL
3	NULL
)	NULL
and	NULL
5	NULL
UTR-3	NULL
'	NULL
UTR	NULL
(	NULL
74	NULL
+	NULL
10	NULL
%	NULL
,	NULL
n	NULL
=	NULL
2	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
CAT	NULL
in	NULL
CMV-CAT	NULL
control	NULL
transfectants	NULL
was	NULL
detected	NULL
under	NULL
all	NULL
conditions	NULL
and	NULL
was	NULL
not	NULL
responsive	NULL
to	NULL
the	NULL
addition	NULL
of	NULL
either	NULL
LPS	NULL
or	NULL
CNI-1493	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Note	NULL
that	NULL
maximal	NULL
suppression	NULL
by	NULL
CNI-1493	NULL
was	NULL
observed	NULL
only	NULL
when	NULL
both	NULL
elements	NULL
were	NULL
present	NULL
,	NULL
suggesting	NULL
that	NULL
suppression	NULL
of	NULL
TNF	NULL
translation	NULL
by	NULL
CNI-1493	NULL
is	NULL
dependent	NULL
upon	NULL
synergy	NULL
between	NULL
the	NULL
5°	NULL
UTR	NULL
and	NULL
3'°	NULL
UTR	NULL
elements	NULL
of	NULL
TNF	NULL
mRNA	NULL
.	NULL

DISCUSSION	NULL
CNI-1493	NULL
is	NULL
a	NULL
potent	NULL
inhibitor	NULL
of	NULL
monocyte/macrophage	NULL
TNF	NULL
synthesis	NULL
.	NULL

The	NULL
present	NULL
data	NULL
now	NULL
give	NULL
direct	NULL
evidence	NULL
that	NULL
pharmacological	NULL
quantities	NULL
of	NULL
CNI-1493	NULL
inhibit	NULL
the	NULL
CNI-1493	NULL
26kDa-	NULL
17kDa-	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

Inhibition	NULL
of	NULL
26-kDa	NULL
TNF	NULL
protein	NULL
synthesis	NULL
by	NULL
CNI-1493	NULL
in	NULL
human	NULL
PBMCs	NULL
.	NULL

Human	NULL
PBMCs	NULL
were	NULL
incubated	NULL
in	NULL
the	NULL
presence	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
or	NULL
absence	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
of	NULL
2.5	NULL
uM	NULL
CNI-1493	NULL
and	NULL
in	NULL
the	NULL
presence	NULL
(	NULL
lanes	NULL
2	NULL
and	NULL
4	NULL
)	NULL
or	NULL
absence	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
3	NULL
)	NULL
of	NULL
LPS	NULL
and	NULL
[	NULL
*S	NULL
$	NULL
Jmethionine	NULL
for	NULL
1	NULL
hr	NULL
.	NULL

Cell	NULL
lysates	NULL
were	NULL
prepared	NULL
and	NULL
immunoprecipitated	NULL
with	NULL
anti-TNF	NULL
antisera	NULL
and	NULL
were	NULL
analyzed	NULL
by	NULL
electrophoresis	NULL
and	NULL
autoradiography	NULL
.	NULL

The	NULL
positions	NULL
of	NULL
the	NULL
TNF	NULL
immuno-reactive	NULL
bands	NULL
are	NULL
identified	NULL
by	NULL
their	NULL
apparent	NULL
molecular	NULL
weights	NULL
on	NULL
the	NULL
left	NULL
.	NULL

3970	NULL
Medical	NULL
Sciences	NULL
:	NULL
Cohen	NULL
et	NULL
al	NULL
.	NULL

%	NULL
CAT	NULL
Conversion	NULL
i	NULL
'-3'UTR	NULL
5'UTR	NULL
5'UTR-3'UTR	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

Effects	NULL
of	NULL
CNI-1493	NULL
on	NULL
LPS-induced	NULL
CAT	NULL
expression	NULL
in	NULL
RAW	NULL
264.7	NULL
cells	NULL
transfected	NULL
with	NULL
CAT-TNF	NULL
constructs	NULL
.	NULL

CNI-1493	NULL
(	NULL
1	NULL
uM	NULL
)	NULL
was	NULL
added	NULL
to	NULL
transfected	NULL
RAW	NULL
264.7	NULL
cells	NULL
for	NULL
1	NULL
hr	NULL
prior	NULL
to	NULL
addition	NULL
of	NULL
LPS	NULL
at	NULL
1	NULL
ug/ml	NULL
or	NULL
to	NULL
uninduced	NULL
controls	NULL
as	NULL
indicated	NULL
.	NULL

CAT	NULL
assay	NULL
was	NULL
performed	NULL
on	NULL
all	NULL
transfected	NULL
cells	NULL
4	NULL
hr	NULL
after	NULL
addition	NULL
of	NULL
LPS	NULL
.	NULL

Results	NULL
shown	NULL
are	NULL
representative	NULL
of	NULL
three	NULL
experiments	NULL
.	NULL

Data	NULL
are	NULL
expressed	NULL
as	NULL
the	NULL
percentage	NULL
of	NULL
total	NULL
CAT	NULL
conversion	NULL
.	NULL

translation	NULL
of	NULL
membrane	NULL
26-kDa	NULL
TNF	NULL
,	NULL
which	NULL
is	NULL
normally	NULL
stimulated	NULL
by	NULL
LPS	NULL
.	NULL

CNI-1493	NULL
did	NULL
not	NULL
inhibit	NULL
early	NULL
nuclear	NULL
translocation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
after	NULL
LPS	NULL
stimulation	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
and	NULL
thereby	NULL
enabled	NULL
significant	NULL
increases	NULL
of	NULL
TNF	NULL
mRNA	NULL
,	NULL
as	NULL
normally	NULL
occurs	NULL
after	NULL
LPS	NULL
stimulation	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

The	NULL
translation	NULL
inhibition	NULL
was	NULL
observed	NULL
to	NULL
be	NULL
dependent	NULL
upon	NULL
both	NULL
the	NULL
3	NULL
'	NULL
and	NULL
5	NULL
'	NULL
UTR	NULL
elements	NULL
of	NULL
the	NULL
TNF	NULL
mRNA	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

We	NULL
have	NULL
previously	NULL
shown	NULL
that	NULL
inhibition	NULL
of	NULL
TNF	NULL
synthesis	NULL
is	NULL
specific	NULL
,	NULL
because	NULL
total	NULL
cellular	NULL
synthesis	NULL
of	NULL
RNA	NULL
and	NULL
protein	NULL
were	NULL
unaffected	NULL
by	NULL
quantities	NULL
of	NULL
CNI-1493	NULL
that	NULL
effectively	NULL
suppress	NULL
TNF	NULL
synthesis	NULL
(	NULL
3	NULL
)	NULL
.	NULL

Previous	NULL
work	NULL
suggests	NULL
that	NULL
after	NULL
macrophage	NULL
activation	NULL
,	NULL
discrete	NULL
signaling	NULL
pathways	NULL
regulate	NULL
the	NULL
p38	NULL
MAP	NULL
kinase-dependent	NULL
increases	NULL
of	NULL
TNF	NULL
translation	NULL
and	NULL
the	NULL
NF-	NULL
«	NULL
B-dependent	NULL
enhancement	NULL
of	NULL
TNF	NULL
transcription	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

Raf-1	NULL
activation	NULL
has	NULL
been	NULL
implicated	NULL
in	NULL
the	NULL
stimulation	NULL
of	NULL
an	NULL
NF-	NULL
«	NULL
B	NULL
pathway	NULL
in	NULL
NIH	NULL
3T3	NULL
cells	NULL
,	NULL
but	NULL
this	NULL
pathway	NULL
has	NULL
not	NULL
been	NULL
confirmed	NULL
in	NULL
monocyte/macrophages	NULL
(	NULL
8	NULL
,	NULL
9	NULL
)	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
that	NULL
these	NULL
signaling	NULL
pathways	NULL
diverge	NULL
upstream	NULL
of	NULL
MEKK	NULL
,	NULL
the	NULL
raf-1	NULL
homolog	NULL
implicated	NULL
in	NULL
activation	NULL
of	NULL
JNK/p38	NULL
MAP	NULL
kinase	NULL
family	NULL
(	NULL
5-7	NULL
)	NULL
.	NULL

The	NULL
present	NULL
results	NULL
place	NULL
the	NULL
TNF-suppressive	NULL
activity	NULL
of	NULL
CNI-1493	NULL
in	NULL
the	NULL
p38	NULL
cascade	NULL
because	NULL
it	NULL
inhibits	NULL
translation	NULL
of	NULL
the	NULL
26-kDa	NULL
prohormone	NULL
but	NULL
does	NULL
not	NULL
inhibit	NULL
the	NULL
translocation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Although	NULL
the	NULL
molecular	NULL
target	NULL
of	NULL
CNI-1493	NULL
remains	NULL
unproved	NULL
,	NULL
the	NULL
inhibitory	NULL
effects	NULL
of	NULL
CNI-1493	NULL
are	NULL
not	NULL
restricted	NULL
to	NULL
LPS-activated	NULL
signaling	NULL
pathways	NULL
because	NULL
it	NULL
suppressed	NULL
TNF	NULL
synthesis	NULL
in	NULL
monocytes	NULL
activated	NULL
by	NULL
exposure	NULL
to	NULL
TSST-1	NULL
(	NULL
3	NULL
)	NULL
,	NULL
a	NULL
stimulating	NULL
agent	NULL
that	NULL
is	NULL
independent	NULL
of	NULL
LPS	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
target	NULL
of	NULL
CNI-1493	NULL
may	NULL
represent	NULL
a	NULL
shared	NULL
signaling	NULL
point	NULL
where	NULL
LPS-	NULL
and	NULL
TSST-induced	NULL
cascades	NULL
converge	NULL
.	NULL

Finally	NULL
,	NULL
it	NULL
will	NULL
be	NULL
of	NULL
interest	NULL
to	NULL
determine	NULL
whether	NULL
the	NULL
site	NULL
of	NULL
action	NULL
is	NULL
proximal	NULL
or	NULL
distal	NULL
to	NULL
p38	NULL
MAP	NULL
kinase	NULL
and	NULL
whether	NULL
CNI-1493	NULL
can	NULL
inactivate	NULL
other	NULL
members	NULL
of	NULL
the	NULL
p38	NULL
MAP	NULL
kinase	NULL
cascade	NULL
(	NULL
e.g	NULL
.	NULL

,	NULL
edc42	NULL
,	NULL
MEKK	NULL
,	NULL
and	NULL
MKK3/MKK4	NULL
)	NULL
(	NULL
5-7	NULL
)	NULL
.	NULL

TNF	NULL
occupies	NULL
a	NULL
proximal	NULL
position	NULL
in	NULL
amplifying	NULL
the	NULL
proinflammatory	NULL
cytokine	NULL
cascade	NULL
in	NULL
LPS-activated	NULL
macrophages	NULL
.	NULL

For	NULL
instance	NULL
,	NULL
neutralization	NULL
of	NULL
TNF	NULL
with	NULL
monoclonal	NULL
antibody	NULL
during	NULL
overwhelming	NULL
infection	NULL
suppressed	NULL
subsequent	NULL
increases	NULL
of	NULL
serum	NULL
IL-1	NULL
and	NULL
IL-6	NULL
despite	NULL
persistent	NULL
bacte-remia	NULL
(	NULL
28	NULL
)	NULL
.	NULL

It	NULL
is	NULL
plausible	NULL
that	NULL
by	NULL
inhibiting	NULL
TNF	NULL
synthesis	NULL
,	NULL
CNI-1493	NULL
might	NULL
prevent	NULL
subsequent	NULL
release	NULL
of	NULL
these	NULL
secondary	NULL
cytokines	NULL
.	NULL

In	NULL
support	NULL
of	NULL
this	NULL
hypothesis	NULL
,	NULL
we	NULL
previously	NULL
showed	NULL
that	NULL
CNI-1493	NULL
inhibited	NULL
proinflammatory	NULL
cy-	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
93	NULL
(	NULL
1996	NULL
)	NULL
tokines	NULL
(	NULL
including	NULL
IL-1	NULL
,	NULL
IL-6	NULL
,	NULL
MIP-1	NULL
@	NULL
,	NULL
)	NULL
,	NULL
iNOS	NULL
,	NULL
and	NULL
cytokine-inducible	NULL
L-arginine	NULL
transporter	NULL
functions	NULL
in	NULL
LPS-stimulated	NULL
macrophages	NULL
(	NULL
2	NULL
,	NULL
3	NULL
)	NULL
.	NULL

It	NULL
will	NULL
be	NULL
of	NULL
interest	NULL
to	NULL
determine	NULL
whether	NULL
CNI-1493	NULL
suppressed	NULL
these	NULL
proinflammatory	NULL
responses	NULL
as	NULL
an	NULL
indirect	NULL
consequence	NULL
of	NULL
TNF	NULL
blockade	NULL
or	NULL
by	NULL
a	NULL
direct	NULL
effect	NULL
that	NULL
suppressed	NULL
a	NULL
shared	NULL
regulatory	NULL
mechanism	NULL
common	NULL
to	NULL
these	NULL
proinflammatory	NULL
mediators	NULL
.	NULL

CNI-1493	NULL
is	NULL
also	NULL
an	NULL
effective	NULL
macrophage	NULL
cytokine	NULL
suppres-sor	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IFN-y	NULL
,	NULL
suggesting	NULL
that	NULL
it	NULL
will	NULL
retain	NULL
its	NULL
effectiveness	NULL
in	NULL
clinical	NULL
conditions	NULL
where	NULL
IFN-y	NULL
is	NULL
ubiquitous	NULL
(	NULL
29	NULL
)	NULL
.	NULL

Because	NULL
IFN-y	NULL
can	NULL
override	NULL
the	NULL
suppression	NULL
of	NULL
TNF	NULL
in	NULL
the	NULL
C3H/HeJ	NULL
mice	NULL
,	NULL
which	NULL
normally	NULL
fail	NULL
to	NULL
produce	NULL
TNF	NULL
in	NULL
response	NULL
to	NULL
LPS	NULL
,	NULL
it	NULL
will	NULL
be	NULL
of	NULL
interest	NULL
to	NULL
use	NULL
CNI-1493	NULL
to	NULL
further	NULL
characterize	NULL
the	NULL
molecular	NULL
basis	NULL
for	NULL
this	NULL
genetic	NULL
defect	NULL
(	NULL
29	NULL
,	NULL
30	NULL
)	NULL
.	NULL

It	NULL
is	NULL
hoped	NULL
that	NULL
these	NULL
studies	NULL
will	NULL
further	NULL
understanding	NULL
of	NULL
the	NULL
mechanism	NULL
of	NULL
macrophage	NULL
activation	NULL
and	NULL
cytokine	NULL
synthesis	NULL
and	NULL
lead	NULL
to	NULL
the	NULL
development	NULL
of	NULL
therapeutic	NULL
strategies	NULL
to	NULL
prevent	NULL
the	NULL
manifestation	NULL
of	NULL
mac-rophage-mediated	NULL
disease	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
in	NULL
part	NULL
by	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
Grants	NULL
RO1	NULL
DK49283	NULL
(	NULL
to	NULL
K.J.T	NULL
.	NULL
)	NULL

and	NULL
RO1	NULL
A121359-10A	NULL
(	NULL
to	NULL
A.C.	NULL
)	NULL
and	NULL
by	NULL
funding	NULL
from	NULL
the	NULL
Picower	NULL
Institute	NULL
and	NULL
Cytokine	NULL
Network	NULL
,	NULL
Inc.	NULL
1	NULL
.	NULL

Tracey	NULL
,	NULL
K.	NULL
J	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
in	NULL
Cytokine	NULL
Handbook	NULL
,	NULL
ed	NULL
.	NULL

Thomson	NULL
,	NULL
A.	NULL
W.	NULL
{	NULL
(	NULL
Academic	NULL
,	NULL
New	NULL
York	NULL
)	NULL
,	NULL
pp	NULL
.	NULL

289-304	NULL
.	NULL

2	NULL
.	NULL

Bianchi	NULL
,	NULL
M.	NULL
,	NULL
Ulrich	NULL
,	NULL
P.	NULL
,	NULL
Bloom	NULL
,	NULL
O.	NULL
,	NULL
Meistrell	NULL
,	NULL
M.	NULL
,	NULL
Zimmerman	NULL
,	NULL
G.	NULL
A.	NULL
,	NULL
Schmidtmayerova	NULL
,	NULL
H.	NULL
,	NULL
Bukrinsky	NULL
,	NULL
M.	NULL
,	NULL
Donnelley	NULL
,	NULL
T.	NULL
,	NULL
Bucala	NULL
,	NULL
R.	NULL
,	NULL
Sherry	NULL
,	NULL
B.	NULL
,	NULL
Manogue	NULL
,	NULL
K.	NULL
R.	NULL
,	NULL
Tortolani	NULL
,	NULL
A.	NULL
J.	NULL
,	NULL
Cerami	NULL
,	NULL
A	NULL
.	NULL

&	NULL
Tracey	NULL
,	NULL
K.	NULL
J	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Mol	NULL
.	NULL

Med	NULL
.	NULL

1	NULL
,	NULL
254-266	NULL
.	NULL

3	NULL
.	NULL

Bianchi	NULL
,	NULL
M.	NULL
,	NULL
Bloom	NULL
,	NULL
O.	NULL
,	NULL
Raabe	NULL
,	NULL
T.	NULL
,	NULL
Cohen	NULL
,	NULL
P.	NULL
S.	NULL
,	NULL
Chesney	NULL
,	NULL
J.	NULL
,	NULL
Sherry	NULL
,	NULL
B.	NULL
,	NULL
Schmidtmayerova	NULL
,	NULL
H.	NULL
,	NULL
Zhang	NULL
,	NULL
X.	NULL
,	NULL
Bukrinsky	NULL
,	NULL
M.	NULL
,	NULL
Ulrich	NULL
,	NULL
P.	NULL
,	NULL
Cerami	NULL
,	NULL
A	NULL
.	NULL

&	NULL
Tracey	NULL
,	NULL
K.	NULL
J	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

,	NULL
in	NULL
press	NULL
.	NULL

4	NULL
.	NULL

-	NULL
Beutler	NULL
,	NULL
B.	NULL
,	NULL
Han	NULL
,	NULL
J.	NULL
,	NULL
Kruys	NULL
,	NULL
V.	NULL
&	NULL
Giroir	NULL
,	NULL
B.	NULL
P.	NULL
(	NULL
1992	NULL
)	NULL
in	NULL
Tumor	NULL
Necrosis	NULL
Factors	NULL
:	NULL
The	NULL
Molecules	NULL
and	NULL
Their	NULL
Emerging	NULL
Role	NULL
in	NULL
Medicine	NULL
,	NULL
ed	NULL
.	NULL

Beutler	NULL
,	NULL
B	NULL
.	NULL

(	NULL
Raven	NULL
,	NULL
New	NULL
York	NULL
)	NULL
,	NULL
pp	NULL
.	NULL

561-574	NULL
.	NULL

5	NULL
.	NULL

Coso	NULL
,	NULL
O	NULL
.	NULL

A.	NULL
,	NULL
Chiarello	NULL
,	NULL
M.	NULL
,	NULL
Yu	NULL
,	NULL
J.-C.	NULL
,	NULL
Teramoto	NULL
,	NULL
H.	NULL
,	NULL
Crespo	NULL
,	NULL
P.	NULL
,	NULL
Xu	NULL
,	NULL
N.	NULL
,	NULL
Miki	NULL
,	NULL
T.	NULL
&	NULL
Gutkind	NULL
,	NULL
J.	NULL
S.	NULL
(	NULL
1995	NULL
)	NULL
Cell	NULL
81	NULL
,	NULL
1137-1146	NULL
.	NULL

6	NULL
.	NULL

Minden	NULL
,	NULL
A.	NULL
,	NULL
Lin	NULL
,	NULL
A.	NULL
,	NULL
Claret	NULL
,	NULL
F.-X	NULL
.	NULL

,	NULL
Abo	NULL
,	NULL
A	NULL
.	NULL

&	NULL
Karin	NULL
,	NULL
M.	NULL
(	NULL
1995	NULL
)	NULL
Cell	NULL
81	NULL
,	NULL
1147-1157	NULL
.	NULL

7	NULL
.	NULL

Derijard	NULL
,	NULL
B.	NULL
,	NULL
Raingeaud	NULL
,	NULL
J.	NULL
,	NULL
Barrett	NULL
,	NULL
T.	NULL
,	NULL
Wu	NULL
,	NULL
L.-H.	NULL
,	NULL
Han	NULL
,	NULL
J.	NULL
,	NULL
Ulevitch	NULL
,	NULL
R.	NULL
J	NULL
.	NULL

&	NULL
Davis	NULL
,	NULL
R.	NULL
J	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Science	NULL
267	NULL
,	NULL
682-685	NULL
.	NULL

8	NULL
.	NULL

Li	NULL
,	NULL
S.	NULL
&	NULL
Sedivy	NULL
,	NULL
J.	NULL
M.	NULL
(	NULL
1993	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90	NULL
,	NULL
9247-9251	NULL
.	NULL

9.	NULL
.	NULL

Hambleton	NULL
,	NULL
J.	NULL
,	NULL
McMahon	NULL
,	NULL
M.	NULL
&	NULL
DeFranco	NULL
,	NULL
A.	NULL
L.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

182	NULL
,	NULL
147-154	NULL
.	NULL

10	NULL
.	NULL

Geppert	NULL
,	NULL
T.	NULL
D.	NULL
,	NULL
Whitehurst	NULL
,	NULL
C.	NULL
E.	NULL
,	NULL
Thompson	NULL
,	NULL
P.	NULL
&	NULL
Beutler	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Mol	NULL
.	NULL

Med	NULL
.	NULL

1	NULL
,	NULL
93-104	NULL
.	NULL

11	NULL
.	NULL

Ishikawa	NULL
,	NULL
Y.	NULL
,	NULL
Mukaida	NULL
,	NULL
N.	NULL
,	NULL
Kun	NULL
,	NULL
K.	NULL
,	NULL
Rice	NULL
,	NULL
M.	NULL
,	NULL
Okamoto	NULL
,	NULL
S.	NULL
&	NULL
Matsushima	NULL
,	NULL
K.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
4158-4164	NULL
.	NULL

12	NULL
.	NULL

Geng	NULL
,	NULL
Y.	NULL
,	NULL
Shang	NULL
,	NULL
B	NULL
.	NULL

&	NULL
Lotz	NULL
,	NULL
M.	NULL
(	NULL
1993	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

151	NULL
,	NULL
6692-6700	NULL
.	NULL

13	NULL
.	NULL

-	NULL
Jongeneel	NULL
,	NULL
C.	NULL
V.	NULL
(	NULL
1992	NULL
)	NULL
in	NULL
Tumor	NULL
Necrosis	NULL
Factors	NULL
:	NULL
The	NULL
Molecules	NULL
and	NULL
Their	NULL
Emerging	NULL
Role	NULL
in	NULL
Medicine	NULL
,	NULL
ed	NULL
.	NULL

Beutler	NULL
,	NULL
B	NULL
.	NULL

(	NULL
Raven	NULL
,	NULL
New	NULL
York	NULL
)	NULL
,	NULL
pp	NULL
.	NULL

539-559	NULL
.	NULL

14	NULL
.	NULL

Wang	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
Doyle	NULL
,	NULL
M.	NULL
V.	NULL
&	NULL
Mark	NULL
,	NULL
D.	NULL
F.	NULL
(	NULL
1989	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
86	NULL
,	NULL
9717-9721	NULL
.	NULL

15	NULL
.	NULL

Wang	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
Creasey	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
,	NULL
Ladner	NULL
,	NULL
M.	NULL
B.	NULL
,	NULL
Lin	NULL
,	NULL
L.	NULL
S.	NULL
,	NULL
Strickler	NULL
,	NULL
J.	NULL
,	NULL
Van	NULL
Arsdell	NULL
,	NULL
J.	NULL
N.	NULL
,	NULL
Yamamoto	NULL
,	NULL
R.	NULL
&	NULL
Mark	NULL
,	NULL
D.	NULL
F.	NULL
(	NULL
1985	NULL
)	NULL
Science	NULL
228	NULL
,	NULL
149-154	NULL
.	NULL

16	NULL
.	NULL

-	NULL
Schulze-Osthoff	NULL
,	NULL
K.	NULL
,	NULL
Beyaert	NULL
,	NULL
R.	NULL
,	NULL
Vandevoorde	NULL
,	NULL
V.	NULL
,	NULL
Haegeman	NULL
,	NULL
G.	NULL
&	NULL
Fiers	NULL
,	NULL
W.	NULL
(	NULL
1993	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

12	NULL
,	NULL
3095-3104	NULL
.	NULL

17	NULL
.	NULL

-	NULL
Jue	NULL
,	NULL
D.-M.	NULL
,	NULL
Sherry	NULL
,	NULL
B.	NULL
,	NULL
Luedke	NULL
,	NULL
C.	NULL
,	NULL
Manogue	NULL
,	NULL
K.	NULL
R.	NULL
&	NULL
Cerami	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Biochemistry	NULL
29	NULL
,	NULL
8371-8377	NULL
.	NULL

18	NULL
.	NULL

-	NULL
Pradines-Figueres	NULL
,	NULL
A	NULL
.	NULL

&	NULL
Raetz	NULL
,	NULL
C.	NULL
R.	NULL
H.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267	NULL
,	NULL
23261-23268	NULL
.	NULL

19	NULL
.	NULL

Han	NULL
,	NULL
J.	NULL
,	NULL
Huez	NULL
,	NULL
G.	NULL
&	NULL
Beutler	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

146	NULL
,	NULL
1843-1848	NULL
.	NULL

20	NULL
.	NULL

Han	NULL
,	NULL
J.	NULL
,	NULL
Thompson	NULL
,	NULL
P.	NULL
&	NULL
Beutler	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

172	NULL
,	NULL
391-394	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

Medical	NULL
Sciences	NULL
:	NULL
Cohen	NULL
et	NULL
al	NULL
.	NULL

Han	NULL
,	NULL
J	NULL
.	NULL

&	NULL
Beutler	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Eur	NULL
.	NULL

Cytokine	NULL
Network	NULL
1	NULL
,	NULL
71-75	NULL
.	NULL

Chen	NULL
,	NULL
C.	NULL
&	NULL
Okayama	NULL
,	NULL
H.	NULL
(	NULL
1987	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

7	NULL
,	NULL
2745-2752	NULL
.	NULL

Sambrook	NULL
,	NULL
J.	NULL
,	NULL
Fritsch	NULL
,	NULL
E.	NULL
F.	NULL
&	NULL
Maniatis	NULL
,	NULL
T.	NULL
(	NULL
1989	NULL
)	NULL
Molecular	NULL
Cloning	NULL
:	NULL
A	NULL
Laboratory	NULL
Manual	NULL
(	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Lab	NULL
.	NULL

Press	NULL
,	NULL
Plainview	NULL
,	NULL
NY	NULL
)	NULL
,	NULL
2nd	NULL
Ed	NULL
.	NULL

Gorman	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
Merlino	NULL
,	NULL
G.	NULL
T.	NULL
,	NULL
Willingham	NULL
,	NULL
M.	NULL
C.	NULL
,	NULL
Pastan	NULL
,	NULL
I	NULL
.	NULL

&	NULL
Howard	NULL
,	NULL
B.	NULL
H.	NULL
(	NULL
1982	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
79	NULL
,	NULL
6777-6781	NULL
.	NULL

Trede	NULL
,	NULL
N.	NULL
S.	NULL
,	NULL
Tsytsykova	NULL
,	NULL
A.	NULL
V.	NULL
,	NULL
Chatila	NULL
,	NULL
T.	NULL
,	NULL
Goldfeld	NULL
,	NULL
A.	NULL
E.	NULL
&	NULL
Geha	NULL
,	NULL
R.	NULL
S.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

155	NULL
,	NULL
902-908	NULL
.	NULL

26	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
93	NULL
(	NULL
1996	NULL
)	NULL
3971	NULL
Goldfeld	NULL
,	NULL
A.	NULL
E.	NULL
,	NULL
Doyle	NULL
,	NULL
C.	NULL
&	NULL
Maniatis	NULL
,	NULL
T.	NULL
(	NULL
1990	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
87	NULL
,	NULL
9769-9773	NULL
.	NULL

Han	NULL
,	NULL
J.	NULL
,	NULL
Brown	NULL
,	NULL
T.	NULL
&	NULL
Beutler	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

171	NULL
,	NULL
465-475	NULL
.	NULL

Fong	NULL
,	NULL
Y.	NULL
,	NULL
Tracey	NULL
,	NULL
K.	NULL
J.	NULL
,	NULL
Moldawer	NULL
,	NULL
L.	NULL
L.	NULL
,	NULL
Hesse	NULL
,	NULL
D.	NULL
G.	NULL
,	NULL
Manogue	NULL
,	NULL
K.	NULL
R.	NULL
,	NULL
Kenney	NULL
,	NULL
J	NULL
.	NULL

$	NULL
.	NULL

,	NULL
Lee	NULL
,	NULL
A.	NULL
T.	NULL
,	NULL
Kuo	NULL
,	NULL
G.	NULL
C.	NULL
,	NULL
Allison	NULL
,	NULL
A.	NULL
C.	NULL
,	NULL
Lowry	NULL
,	NULL
S.	NULL
F.	NULL
&	NULL
Cerami	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

170	NULL
,	NULL
1627-1633	NULL
.	NULL

Beutler	NULL
,	NULL
B.	NULL
,	NULL
Krochin	NULL
,	NULL
M.	NULL
,	NULL
Milsark	NULL
,	NULL
I.	NULL
W.	NULL
,	NULL
Luedke	NULL
,	NULL
C.	NULL
&	NULL
Cerami	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
Science	NULL
232	NULL
,	NULL
977-980	NULL
.	NULL

Beutler	NULL
,	NULL
B.	NULL
,	NULL
Tkacenko	NULL
,	NULL
V.	NULL
,	NULL
Milsark	NULL
,	NULL
I.	NULL
,	NULL
Krochin	NULL
,	NULL
N.	NULL
&	NULL
Cerami	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

164	NULL
,	NULL
1791-1796	NULL
.	NULL

